Show Search Form
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Nusinersen | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL15576 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what discussions they have had with (1) NICE, (2) NHS England, and (3) Biogen, on a Managed Access Agreement for Spinal Muscular Atrophy treatment, Spinraza. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL15576 | ||||||||||||||
type |
|
||||||||||||||
uin | HL15576 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | National Institute for Health and Care Excellence | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL15577 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government when they estimate that NICE will publish the outcome of the NICE Evaluation Committee meeting held on 6 March. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL15577 | ||||||||||||||
type |
|
||||||||||||||
uin | HL15577 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Pneumococcal Diseases: Vaccination | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL15599 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what assessment they have made of the recommendations by the Joint Committee on Vaccination and Immunisation to reduce the infant pneumococcal vaccination schedule from three doses to two. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL15599 | ||||||||||||||
type |
|
||||||||||||||
uin | HL15599 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Idiopathic Pulmonary Fibrosis | ||||||||||||||
house id | 1 | ||||||||||||||
identifier | 250788 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask the Secretary of State for Health and Social Care, what steps he is taking to improve (a) early diagnosis and (b) treatment of idiopathic pulmonary fibrosis. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member constituency | Stevenage | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 250788 | ||||||||||||||
type |
|
||||||||||||||
uin | 250788 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Haemophilia: Medical Treatments | ||||||||||||||
house id | 1 | ||||||||||||||
identifier | 251321 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that haemophilia patients receive (a) appropriate access to physiotherapy, (b) a regular clinical review, and (c) tailored dosing of treatments in accordance with NHS England’s service specification. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member constituency | Strangford | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 251321 | ||||||||||||||
type |
|
||||||||||||||
uin | 251321 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Haemophilia: Medical Treatments | ||||||||||||||
house id | 1 | ||||||||||||||
identifier | 251322 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the Commercial Medicines Unit’s national tender framework for factor VIII haemophilia products on patient access to extended half-life medicines. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member constituency | Strangford | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 251322 | ||||||||||||||
type |
|
||||||||||||||
uin | 251322 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Blood Diseases: Medical Treatments | ||||||||||||||
house id | 1 | ||||||||||||||
identifier | 251323 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask the Secretary of State for Health and Social Care, what steps he NHS England is taking to ensure that patients with bleeding disorders have adequate access to treatment options that meet individual patient need. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member constituency | Strangford | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 251323 | ||||||||||||||
type |
|
||||||||||||||
uin | 251323 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Haemophilia: Medical Treatments | ||||||||||||||
house id | 1 | ||||||||||||||
identifier | 251324 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask the Secretary of State for Health and Social Care, whether NHS England has made an assessment of the adequacy of the availability of Haemtrack in Haemophilia centres. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member constituency | Strangford | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 251324 | ||||||||||||||
type |
|
||||||||||||||
uin | 251324 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Hospitals: Infectious Diseases | ||||||||||||||
house id | 1 | ||||||||||||||
identifier | 251326 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 March 2019 to Question 231466 on Hospitals: Infectious Diseases, whether work of Public Health England will also include as assessment of the effect of changes to ophthalmic surgical practice on trends in the level of risk of infection rates in hospitals. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member constituency | Strangford | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 251326 | ||||||||||||||
type |
|
||||||||||||||
uin | 251326 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Ophthalmic Services | ||||||||||||||
house id | 1 | ||||||||||||||
identifier | 251327 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 March 2019 to Question 231467 on Ophthalmic Services, whether he has made an assessment of the ability for clinicians to take into account patients’ wishes for concomitant treatment in relation to potential restrictions of the 2019/2020 NHS Tariff. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member constituency | Strangford | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 251327 | ||||||||||||||
type |
|
||||||||||||||
uin | 251327 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|